95 related articles for article (PubMed ID: 28599430)
1. Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.
Yang L; Huang M; Tan J; Hou J; He J; Wang F; Cui H; Yi L
Oncol Lett; 2017 Jun; 13(6):4295-4301. PubMed ID: 28599430
[TBL] [Abstract][Full Text] [Related]
2. Validation of chemical compound library screening for transcriptional co-activator with PDZ-binding motif inhibitors using GFP-fused transcriptional co-activator with PDZ-binding motif.
Nagashima S; Maruyama J; Kawano S; Iwasa H; Nakagawa K; Ishigami-Yuasa M; Kagechika H; Nishina H; Hata Y
Cancer Sci; 2016 Jun; 107(6):791-802. PubMed ID: 27009852
[TBL] [Abstract][Full Text] [Related]
3. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins.
Kanai F; Marignani PA; Sarbassova D; Yagi R; Hall RA; Donowitz M; Hisaminato A; Fujiwara T; Ito Y; Cantley LC; Yaffe MB
EMBO J; 2000 Dec; 19(24):6778-91. PubMed ID: 11118213
[TBL] [Abstract][Full Text] [Related]
4. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.
Wang S; Ma K; Chen L; Zhu H; Liang S; Liu M; Xu N
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515420
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.
Li Y; Li L; Zhu M; Ye L; Yang Q
Exp Ther Med; 2017 Oct; 14(4):3831-3835. PubMed ID: 29042987
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-141 inhibits tumor growth and metastasis in gastric cancer by directly targeting transcriptional co-activator with PDZ-binding motif, TAZ.
Zuo QF; Zhang R; Li BS; Zhao YL; Zhuang Y; Yu T; Gong L; Li S; Xiao B; Zou QM
Cell Death Dis; 2015 Jan; 6(1):e1623. PubMed ID: 25633292
[TBL] [Abstract][Full Text] [Related]
7. TAZ antagonizes the WWP1-mediated KLF5 degradation and promotes breast cell proliferation and tumorigenesis.
Zhao D; Zhi X; Zhou Z; Chen C
Carcinogenesis; 2012 Jan; 33(1):59-67. PubMed ID: 22045023
[TBL] [Abstract][Full Text] [Related]
8. Suppression of microRNA-125a-5p upregulates the TAZ-EGFR signaling pathway and promotes retinoblastoma proliferation.
Zhang Y; Xue C; Zhu X; Zhu X; Xian H; Huang Z
Cell Signal; 2016 Aug; 28(8):850-60. PubMed ID: 27094723
[TBL] [Abstract][Full Text] [Related]
9. TAZ Induction Directs Differentiation of Thyroid Follicular Cells from Human Embryonic Stem Cells.
Ma R; Morshed SA; Latif R; Davies TF
Thyroid; 2017 Feb; 27(2):292-299. PubMed ID: 27829313
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a novel compound that promotes myogenesis via Akt and transcriptional co-activator with PDZ-binding motif (TAZ) in mouse C2C12 cells.
Kodaka M; Mao F; Arimoto-Matsuzaki K; Kitamura M; Xu X; Yang Z; Nakagawa K; Maruyama J; Ishii K; Akazawa C; Oyaizu T; Yamamoto N; Ishigami-Yuasa M; Tsuemoto N; Ito S; Kagechika H; Nishina H; Hata Y
PLoS One; 2020; 15(4):e0231265. PubMed ID: 32267872
[TBL] [Abstract][Full Text] [Related]
11. Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression.
Xie D; Cui J; Xia T; Jia Z; Wang L; Wei W; Zhu A; Gao Y; Xie K; Quan M
Oncotarget; 2015 Nov; 6(34):35949-63. PubMed ID: 26416426
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional coactivator with PDZ-binding motif is required to sustain testicular function on aging.
Jeong MG; Song H; Shin JH; Jeong H; Kim HK; Hwang ES
Aging Cell; 2017 Oct; 16(5):1035-1042. PubMed ID: 28613007
[TBL] [Abstract][Full Text] [Related]
13. AMOTL2 interaction with TAZ causes the inhibition of surfactant proteins expression in lung cells.
Lucci V; Di Palma T; D'Ambrosio C; Scaloni A; Zannini M
Gene; 2013 Oct; 529(2):300-6. PubMed ID: 23911299
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-185 suppresses pancreatic cell proliferation by targeting transcriptional coactivator with PDZ-binding motif in pancreatic cancer.
Xia D; Li X; Niu Q; Liu X; Xu W; Ma C; Gu H; Liu Z; Shi L; Tian X; Chen X; Zhang Y
Exp Ther Med; 2018 Jan; 15(1):657-666. PubMed ID: 29399068
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional co-activator TAZ sustains proliferation and tumorigenicity of neuroblastoma by targeting CTGF and PDGF-β.
Wang M; Liu Y; Zou J; Yang R; Xuan F; Wang Y; Gao N; Cui H
Oncotarget; 2015 Apr; 6(11):9517-30. PubMed ID: 25940705
[TBL] [Abstract][Full Text] [Related]
16. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
[TBL] [Abstract][Full Text] [Related]
17. Correlation between the coexpression of zinc finger and SCAN domain-containing protein 31 and transcriptional activator with PDZ-binding motif and prognosis in hepatocellular carcinoma.
Liu Q; Shi Z; Liu X; Xiao H
Ann Transl Med; 2020 Oct; 8(20):1308. PubMed ID: 33209888
[TBL] [Abstract][Full Text] [Related]
18. The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.
Wang Y; Nie H; Li H; Liao Z; Yang X; He X; Ma J; Zhou J; Ou C
Front Med (Lausanne); 2022; 9():888093. PubMed ID: 35865173
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Phosphopeptide Positional Isomers on the Transcriptional Co-activator TAZ.
Roberto J; Sykes CE; Vacratsis PO
Biochemistry; 2020 Nov; 59(43):4148-4154. PubMed ID: 33086783
[TBL] [Abstract][Full Text] [Related]
20. TAZ mediates lysophosphatidic acid-induced migration and proliferation of epithelial ovarian cancer cells.
Jeong GO; Shin SH; Seo EJ; Kwon YW; Heo SC; Kim KH; Yoon MS; Suh DS; Kim JH
Cell Physiol Biochem; 2013; 32(2):253-63. PubMed ID: 23942151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
